OnKure Therapeutics OKUR
NASDAQ OKUR
$3.94 +0.01 (+0.25%)
At close: Aug 21, 2026 · 4:00 PM EDT

OnKure Therapeutics (OKUR) Amortizatization of Intangibles (2020 - 2024)

OnKure Therapeutics' (OKUR) quarterly Amortizatization of Intangibles came in at $260000.0 in Q3 2024, down 83.12% YoY from $1.5 million in Q4 2023, and down 64.77% on a QoQ basis from $738000.0 in Q2 2024.

OnKure Therapeutics (OKUR) Amortizatization of Intangibles (2020 - 2024) Analysis & Trends

OnKure Therapeutics (OKUR) has 5 years of Amortizatization of Intangibles data on file, last reported at $260000.0 in Q3 2024.

  • Quarterly Amortizatization of Intangibles fell 83.12% year-over-year to $260000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $3.1 million (down 25.46% YoY) and the FY2023 annual result came in at $4.8 million, up 484.7% from the prior year.
  • Amortizatization of Intangibles fell to $260000.0 in Q3 2024, from $738000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $1.5 million in Q3 2023 to a low of -$89000.0 in Q4 2021.
  • A 5-year average of $459125.0 and a median of $203500.0 in 2022 frame the typical range for Amortizatization of Intangibles.
  • Annual changes were most pronounced in 2021 — Amortizatization of Intangibles slumped 8100.0% — and 2023, when it soared 77100.0%.
  • Tracing OKUR's Amortizatization of Intangibles over 5 years: stood at $1000.0 in 2020, then plunged by 9000.0% to -$89000.0 in 2021, then jumped by 828.09% to $648000.0 in 2022, then surged by 89.2% to $1.2 million in 2023, then slumped by 78.79% to $260000.0 in 2024.
  • The last three Amortizatization of Intangibles figures came in at $260000.0 (Q3 2024), $738000.0 (Q2 2024), and $906000.0 (Q1 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 OnKure Therapeutics 195.74 Mn 19.35 Mn - 101,000.00

Historic Data

Download Data
DateValue
Sep 30, 2024 260,000.00
Sep 30, 2024 260,000.00
Jun 30, 2024 738,000.00
Jun 30, 2024 738,000.00
Mar 31, 2024 906,000.00
Mar 31, 2024 906,000.00
Dec 31, 2023 1.23 Mn
Dec 31, 2023 1.23 Mn
Sep 30, 2023 1.54 Mn
Sep 30, 2023 1.54 Mn
Jun 30, 2023 1.24 Mn
Jun 30, 2023 1.24 Mn
Mar 31, 2023 770,000.00
Mar 31, 2023 770,000.00
Dec 31, 2022 648,000.00
Dec 31, 2022 648,000.00
Sep 30, 2022 147,000.00
Sep 30, 2022 147,000.00
Jun 30, 2022 23,000.00
Jun 30, 2022 23,000.00